SCHEMBL2633718

SCHEMBL2633718

Oc1cnc(-c2c[nH]c3ncc(Cl)cc23)nc1N1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14327576 0.82 JAK2 (0.39) JAK2
SCHEMBL14465247 0.79 MEN1 (0.51) —
SCHEMBL2630113 0.74 — —
SCHEMBL2633521 0.73 — —
SCHEMBL2633717 0.73 — —
SCHEMBL2630381 0.72 — —
SCHEMBL8941819 0.71 JAK2 (0.51) JAK2
SCHEMBL14327598 0.71 JAK2 (0.38) JAK2
SCHEMBL8940073 0.70 CCNT1 (0.68) JAK2
SCHEMBL18629084 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163917-B2 Azaindoles useful as inhibitors of Janus kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-24 — — US disclosed
Send feedback